Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer-Reference-Cited by-同舟云学术

Transcriptional Reprogramming and Inhibition of Tumor-propagating Stem-like Cells by EC-8042 in ERG-positive Prostate Cancer

Published:2019-07 Issue:4 Volume:2 Page:415-424
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Shinde Dheeraj,Albino Domenico,Zoma Marita,Mutti Azzurra,Mapelli Sarah N.,Civenni Gianluca,Kokanovic Aleksandra,Merulla Jessica,Perez-Escuredo Jhudit,Costales Paula,Morìs Francisco,Catapano Carlo V.,Carbone Giuseppina M.

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference47 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. The diagnosis and treatment of prostate cancer: a review;Litwin;JAMA,2017

3. Recurrent gene fusions in prostate cancer;Kumar-Sinha;Nat Rev Cancer,2008

4. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer;Tomlins;Science,2005

5. Role of the TMPRSS2-ERG gene fusion in prostate cancer;Tomlins;Neoplasia,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mithramycin and its analogs: Molecular features and antitumor action;Pharmacology & Therapeutics;2024-08

2. Mithramycin delivery systems to develop effective therapies in sarcomas;Journal of Nanobiotechnology;2021-09-06

3. Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer;Communications Biology;2021-01-26

4. Targetable gene fusions and aberrations in genitourinary oncology;Nature Reviews Urology;2020-10-12

5. Mithramycin A and Mithralog EC-8042 Inhibit SETDB1 Expression and Its Oncogenic Activity in Malignant Melanoma;Molecular Therapy - Oncolytics;2020-09